Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464294 · ClinicalTrials.gov registry record
Clinical Evaluation of Chairside CAD/CAM Nano-ceramic Restorations
A clinical trial, sponsored by Solventum US.
- Terminated
- Registry status
- 120
- Enrollment target
NCT01464294: Clinical Trial study, sponsored by Solventum US.
NCT01464294 is a clinical trial that was terminated before completion, run by Solventum US. The registered enrollment target is 120 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01464294 was terminated before completion, sponsored by Solventum US.
- TERMINATED
- Registry status
- 120 participants
- Enrollment target
Study Summary
Study aim is to test whether nano-composite CAD/CAM milled restorations have a similar performance in clinical service to conventional ceramic CAD/CAM restorations.
Primary Outcome
Subjective evaluation of restorations using USPHS criteria
Interventions
- DEVICE Milled ceramic restorations
- DEVICE Milled nano-composite restorations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-10 |
| Est. Completion | 2014-12 |
Why NCT01464294 stopped before completion
NCT01464294 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Milled ceramic restorations is the first listed.
NCT01464294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01464294 about?
NCT01464294 is a clinical study titled "Clinical Evaluation of Chairside CAD/CAM Nano-ceramic Restorations". Study aim is to test whether nano-composite CAD/CAM milled restorations have a similar performance in clinical service to conventional ceramic CAD/CAM restorations.
What is the current status of trial NCT01464294?
This trial is currently terminated. The enrollment target is 120 participants. The study started on 2011-10. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01464294?
The interventions under investigation include: Milled ceramic restorations (DEVICE), Milled nano-composite restorations (DEVICE).
Who is sponsoring clinical trial NCT01464294?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia